Biomedical Potentialities of Silver Nanoparticles for Clinical Multiple Drug-Resistant Acinetobacter baumannii

Table 1

Clinical characteristics of three blood isolated samples.

Drug	#1			#2			#3
	KB	MIC	Sensitive/resistant	KB	MIC	Sensitive/resistant	KB	MIC	Sensitive/resistant
Piperacillin		≥128	R		≥128	R		≥128	R
Piperacillin/tazobactam		≥128	R		≥128	R		≥128	R
Ampicillin/sulbactam		≥32	R		8	S		≥32	R
Imipenem		≥16	R		≥16	R		≥16	R
Meropenem		≥16	R		≥16	R		≥16	R
Ceftriaxone		≥64	R		≥64	R		≥64	R
Ceftazidime/cefepime		≥64	R		≥64	R		≥64	R
Gentamicin		≥16	R		≥16	R		≥16	R
Tobramycin		≥16	R		≥16	R		≥16	R
Amikacin	11		R	12		R	11		R
Ciprofloxacin		≥4	R		≥4	R		≥4	R
Levofloxacin		≥8	R		≥8	R		≥8	R
Trimethoprim/sulfamethoxazole		≥20	R		≥20	R		≥320	R
Minocycline	18		S	21		S	17		S

mm; μg/ml.